Nephrology

Renal Cell Carcinoma

Questions discussed in this category

Would you offer adjuvant immunotherapy in a patient with high risk RCC with new/worsening post-op renal dysfunction and CrCl<30?

KEYNOTE-564 required CrCl 30 or above. Not having a baseline/stable CrCl may make it difficult to diagnose or treat IO nephritis.

1 Answer available

How do you manage hyponatremia in patients with renal cell carcinoma on cabozantinib and nivolumab?

2 Answers available

Papers discussed in this category

Cancer, 2017-06-01

Immune checkpoint inhibitors in challenging populations.

N Engl J Med,

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.

Cancers, 2022 May 17

Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers.

International journal of urology : official journal of the Japanese Urological Association, 2023 Jun 06

Tolerability of immune checkpoint inhibitor doublet for advanced renal cell carcinoma patients with pre-dialysis chronic kidney disease or end-stage renal disease.

Related Topics in Nephrology